Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year 
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results Montecito Medical Acquires Medical Office Property in Tampa
NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has completed the…
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Palisade Bio Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Carlsbad, CA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq
• Maximum Potential Dilution of Approximately 23.04%, Based on Share Capital of Cellectis as of…
Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the…
OpGen Announced 1-for-20 Reverse Stock Split
ROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the…
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused…
Celularity Appoints Paul Graves as Chief Communications Officer
Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience FLORHAM…
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…
Oncternal Therapeutics Announces the Appointment of Jill DeSimone to the Board of Directors
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
HilleVax to Present at the 41st Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Y-mAbs Announces Restructuring Plan and Provides Financial Outlook Following Complete Response Letter from FDA
Estimated 28% reduction in annual operating expenses for 2023 compared to previously announced guidance for…
89bio Provides Business Update and Outlook for 2023
– Topline results from ENLIVEN Phase 2b NASH trial on track for first quarter of…
Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Data Read-Outs from Both Programs
Strong Cash Position with Runway into Fourth Quarter 2024 Non-Clinical Data on Immunosuppression Regimen Supportive…
Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
Proposed changes are expected to be beneficial to the lanifibranor clinical program by reducing the…
Lowell Farms Inc. and The Pharm, LLC to Bring the Award-Winning Lowell Smokes to Arizona Dispensaries
California cannabis leader continues multi-state expansion with the launch in Arizona in early 2023 SALINAS,…
University of Phoenix alum Dr. McCarthy Ijiebor receives Cochran Fellowship
The fellowship provides training to agricultural professionals from emerging markets PHOENIX–(BUSINESS WIRE)–University of Phoenix is…
DRS Imaging Services Announces Name Change to Daida
Document management company changes name to reflect their full spectrum of data and business automation…